Assertio Therapeutics
ASRT
#9526
Rank
โ‚ฌ64.16 M
Marketcap
0,67ย โ‚ฌ
Share price
-0.67%
Change (1 day)
-24.27%
Change (1 year)

EPS for Assertio Therapeutics (ASRT)

EPS in 2025 (TTM): -0,28ย โ‚ฌ

According to Assertio Therapeutics 's latest financial reports the company's current EPS (TTM) is -0,26ย โ‚ฌ. In 2024 the company made an earnings per share (EPS) of -0,20ย โ‚ฌ.

EPS history for Assertio Therapeutics from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-0,28ย โ‚ฌ40.08%
2024-0,20ย โ‚ฌ
20221,97ย โ‚ฌ-11550%
2021-0,01720ย โ‚ฌ-96.08%
2020-0,44ย โ‚ฌ-95.79%
2019-10,42ย โ‚ฌ-622.41%
20182,00ย โ‚ฌ-135.58%
2017-5,61ย โ‚ฌ13.19%
2016-4,95ย โ‚ฌ13.39%
2015-4,37ย โ‚ฌ-156.44%
20147,74ย โ‚ฌ200%
20132,58ย โ‚ฌ-238.89%
2012-1,86ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Onconova Therapeutics
ONTX
-0,82ย โ‚ฌ 216.67%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
-0,21ย โ‚ฌ-20.00%๐Ÿ‡บ๐Ÿ‡ธ USA